Richmond, CA, United States of America

Michael A Kuzyk


Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2007-2010

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Michael A Kuzyk: Innovator in Protein Toxins and Secretion Systems

Introduction

Michael A Kuzyk is a prominent inventor based in Richmond, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of protein toxins and secretion systems. With a total of six patents to his name, Kuzyk's work has implications for diagnostics, therapeutics, and vaccine development.

Latest Patents

Among his latest patents, one notable invention is a protein toxin named exoenzyme T (AexT). This toxin belongs to the family of ADP-ribosylating toxins and is disclosed as a novel calcium (or other cation concentration) dependent promoter. The patent also outlines diagnostic, preventive, and therapeutic techniques, including the preparation of bacterin vaccines based on AexT for inducing immunity against infections. Another significant patent involves a newly identified and characterized type III secretion system. This invention encompasses the use of components of the novel secretion system in immunoprotection against infections, as well as other diagnostic and therapeutic applications.

Career Highlights

Throughout his career, Michael A Kuzyk has worked with various research institutions, contributing to advancements in his field. His innovative work has garnered attention and respect within the scientific community.

Collaborations

Kuzyk has collaborated with notable colleagues such as Joachim Frey and Jan Burian. These partnerships have further enhanced his research and development efforts.

Conclusion

Michael A Kuzyk's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in diagnostics and therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…